Publications by authors named "S S Karuppagounder"

Pathologic α-synuclein (α-syn) spreads from cell-to-cell, in part, through binding to the lymphocyte-activation gene 3 (Lag3). Here we report that amyloid β precursor-like protein 1 (Aplp1) interacts with Lag3 that facilitates the binding, internalization, transmission, and toxicity of pathologic α-syn. Deletion of both Aplp1 and Lag3 eliminates the loss of dopaminergic neurons and the accompanying behavioral deficits induced by α-syn preformed fibrils (PFF).

View Article and Find Full Text PDF

Interspecies chimeras offer great potential for regenerative medicine and the creation of human disease models. Whether human pluripotent stem cell-derived neurons in an interspecies chimera can differentiate into functional neurons and integrate into host neural circuity is not known. Here, we show, using Engrailed 1 (En1) as a development niche, that human naive-like embryonic stem cells (ESCs) can incorporate into embryonic and adult mouse brains.

View Article and Find Full Text PDF

Pathologic α-synuclein plays an important role in the pathogenesis of α-synucleinopathies such as Parkinson's disease (PD). Disruption of proteostasis is thought to be central to pathologic α-synuclein toxicity; however, the molecular mechanism of this deregulation is poorly understood. Complementary proteomic approaches in cellular and animal models of PD were used to identify and characterize the pathologic α-synuclein interactome.

View Article and Find Full Text PDF
Article Synopsis
  • - The Stroke Preclinical Assessment Network (SPAN) was created to address concerns about the reliability of preclinical testing for new stroke treatments, following recent failures in clinical trials.
  • - SPAN conducted a rigorous multi-laboratory trial using various animal models to assess candidate treatments in a controlled manner, ensuring aspects like treatment masking and randomization were properly implemented.
  • - By following a standardized protocol across six labs and successfully enrolling a large number of animals, SPAN aims to enhance reproducibility in preclinical research, potentially applying its framework to other medical research areas.
View Article and Find Full Text PDF